6:47 PM
 | 
Jul 29, 2008
 |  BC Extra  |  Company News

EC approves Schering-Plough's Bridion

The EC approved Bridion sugammadex from Schering-Plough (NYSE:SGP) for reversal of muscle relaxants...

Read the full 57 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >